Literature DB >> 23141798

Cancer, epigenetics and the Nobel Prizes.

Manel Esteller.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23141798      PMCID: PMC5528345          DOI: 10.1016/j.molonc.2012.10.004

Source DB:  PubMed          Journal:  Mol Oncol        ISSN: 1574-7891            Impact factor:   6.603


× No keyword cloud information.
  12 in total

1.  Intronic RNAs mediate EZH2 regulation of epigenetic targets.

Authors:  Sònia Guil; Marta Soler; Anna Portela; Jordi Carrère; Elena Fonalleras; Antonio Gómez; Alberto Villanueva; Manel Esteller
Journal:  Nat Struct Mol Biol       Date:  2012-06-03       Impact factor: 15.369

Review 2.  Histone deacetylases and cancer.

Authors:  Bruna Barneda-Zahonero; Maribel Parra
Journal:  Mol Oncol       Date:  2012-08-27       Impact factor: 6.603

Review 3.  The role of histone demethylases in cancer therapy.

Authors:  Inga Hoffmann; Martin Roatsch; Martin L Schmitt; Luca Carlino; Martin Pippel; Wolfgang Sippl; Manfred Jung
Journal:  Mol Oncol       Date:  2012-08-07       Impact factor: 6.603

4.  A DNA methylation fingerprint of 1628 human samples.

Authors:  Agustin F Fernandez; Yassen Assenov; Jose Ignacio Martin-Subero; Balazs Balint; Reiner Siebert; Hiroaki Taniguchi; Hiroyuki Yamamoto; Manuel Hidalgo; Aik-Choon Tan; Oliver Galm; Isidre Ferrer; Montse Sanchez-Cespedes; Alberto Villanueva; Javier Carmona; Jose V Sanchez-Mut; Maria Berdasco; Victor Moreno; Gabriel Capella; David Monk; Esteban Ballestar; Santiago Ropero; Ramon Martinez; Marta Sanchez-Carbayo; Felipe Prosper; Xabier Agirre; Mario F Fraga; Osvaldo Graña; Luis Perez-Jurado; Jaume Mora; Susana Puig; Jaime Prat; Lina Badimon; Annibale A Puca; Stephen J Meltzer; Thomas Lengauer; John Bridgewater; Christoph Bock; Manel Esteller
Journal:  Genome Res       Date:  2011-05-25       Impact factor: 9.043

Review 5.  HDAC inhibitor-based therapies: can we interpret the code?

Authors:  Maria New; Heidi Olzscha; Nicholas B La Thangue
Journal:  Mol Oncol       Date:  2012-10-23       Impact factor: 6.603

6.  Distinct DNA methylomes of newborns and centenarians.

Authors:  Holger Heyn; Ning Li; Humberto J Ferreira; Sebastian Moran; David G Pisano; Antonio Gomez; Javier Diez; Jose V Sanchez-Mut; Fernando Setien; F Javier Carmona; Annibale A Puca; Sergi Sayols; Miguel A Pujana; Jordi Serra-Musach; Isabel Iglesias-Platas; Francesc Formiga; Agustin F Fernandez; Mario F Fraga; Simon C Heath; Alfonso Valencia; Ivo G Gut; Jun Wang; Manel Esteller
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-11       Impact factor: 11.205

Review 7.  Detection of cancer-specific epigenomic changes in biofluids: powerful tools in biomarker discovery and application.

Authors:  André Nogueira da Costa; Zdenko Herceg
Journal:  Mol Oncol       Date:  2012-08-16       Impact factor: 6.603

Review 8.  MicroRNA and cancer.

Authors:  Martin D Jansson; Anders H Lund
Journal:  Mol Oncol       Date:  2012-10-09       Impact factor: 6.603

Review 9.  Trials with 'epigenetic' drugs: an update.

Authors:  Angela Nebbioso; Vincenzo Carafa; Rosaria Benedetti; Lucia Altucci
Journal:  Mol Oncol       Date:  2012-10-06       Impact factor: 6.603

Review 10.  DNA methylation profiling in the clinic: applications and challenges.

Authors:  Holger Heyn; Manel Esteller
Journal:  Nat Rev Genet       Date:  2012-09-04       Impact factor: 53.242

View more
  1 in total

1.  Decreased fructose-1,6-bisphosphatase-2 expression promotes glycolysis and growth in gastric cancer cells.

Authors:  He Li; Juan Wang; Huiyu Xu; Rui Xing; Yuanming Pan; Wenmei Li; Jiantao Cui; Hongbing Zhang; Youyong Lu
Journal:  Mol Cancer       Date:  2013-09-25       Impact factor: 27.401

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.